Finnerty Thomas 4

4 · Anika Therapeutics, Inc. · Filed Feb 28, 2022

Form 4

Period: 2022-02-25

Chief Human Resources Officer

Transactions

Exercise/Conversion
Common Stock
2022-02-25+2,834→ 21,511 total
Tax Payment
Common Stock
2022-02-25$32.13/sh−832$26,732→ 20,679 total
Tax Payment
Common Stock
2022-02-26$32.13/sh−881$28,307→ 22,798 total
Exercise/Conversion
Common Stock
2022-02-26+3,000→ 23,679 total
Exercise/Conversion
Restricted Stock Unit
2022-02-25−2,834→ 2,833 total
Exercise: $0.00→ Common Stock (2,834 underlying)
Exercise/Conversion
Restricted Stock Unit
2022-02-26−3,000→ 0 total
Exercise: $0.00→ Common Stock (3,000 underlying)

Footnotes (7)

[F1]Reflects the second vesting installment of Restricted Stock Units (RSUs) granted on February 25, 2020.
[F2]Reflects an aggregate of 832 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on February 25, 2022.
[F3]Reflects the closing price of ANIK common stock on February 25, 2022, the trading day on which the vesting of RSUs gave rise to tax withholding obligations.
[F4]Reflects the third vesting installment of RSUs granted on February 26, 2019.
[F5]Reflects an aggregate of 881 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on February 26, 2022.
[F6]Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning February 25, 2021.
[F7]Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning February 26, 2020.

Documents

1 file